Skip to content

Respiratory Health of Elite Athletes

Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00686491
Acronym
cold air
Enrollment
133
Registered
2008-05-29
Start date
2007-06-30
Completion date
2010-12-31
Last updated
2011-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Cardiovascular Diseases, Metabolic Diseases

Keywords

Asthma, Environment, Type of sport, Cardiovascular disease, Athletes

Brief summary

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area. Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be 1. to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes. 2. to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes 3. to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.

Interventions

None listed

Sponsors

Laval University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Athletes training more than 10 hours per week-

Exclusion criteria

* asthma or other pathologies that may interfere with the study * Smokers * Obese of with a BMI more than 29

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026